Search
for
Sort by
Research 391–420 of 1000+
- Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia
- A systematic review of pulse steroid therapy for alopecia areata
- Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study
- Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis
- Alopecia Areata
- Topical Treatment of Alopecia Areata
- Alopecia secondary to mesotherapy
- Post-menopausal frontal fibrosing alopecia
- Optimal Management of Hair Loss (Alopecia) in Children
- Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Drug-induced alopecia after dupilumab therapy
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children
- Alopecia areata update
- Alopecia Areata
- Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- Alopecia With Endocrine Therapies in Patients With Cancer
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Treatment of pediatric alopecia areata: A systematic review
- Scalp bacterial shift in Alopecia areata
- Alopecia areata and the gut—the link opens up for novel therapeutic interventions
- Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta‐analysis
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata